Ϫ secretion across polarized monolayers. However, when the basolateral membrane was permeabilized, butyrate, but not the other experimental maneuvers, increased the CPTcAMP-stimulated Cl Ϫ current across the apical plasma membrane. Thus butyrate increased the amount of functional ⌬F508-CFTR in the apical plasma membrane. Butyrate failed to stimulate transepithelial Cl Ϫ secretion because of inhibitory effects on Cl Ϫ uptake across the basolateral membrane. These observations suggest that studies on heterologous and nonpolarized cells should be interpreted cautiously. The GFP tag on ⌬F508-CFTR will allow investigation of ⌬F508-CFTR trafficking in living, polarized MDCK epithelial cells in real time. cystic fibrosis; Madin-Darby canine kidney; butyrate; glycerol; dimethyl sulfoxide; green fluorescent protein; cystic fibrosis transmembrane conductance regulator THE CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULA-TOR (CFTR), a cAMP-activated Cl Ϫ channel, is expressed in a wide variety of epithelial cells, including airway and kidney (13, 46) . Mutations in the CFTR gene lead to the genetic disease cystic fibrosis (CF), a lethal autosomal recessive disorder (30, 40) . Approximately 70% of individuals with CF are homozygous for the ⌬F508-CFTR mutation, which accounts for approximately 90% of all mutant CFTR alleles (30) . Trafficking of ⌬F508-CFTR from the endoplasmic reticulum (ER) to the apical plasma membrane of epithelial cells is extremely inefficient. Moreover, ⌬F508-CFTR has a relatively short residence time in the plasma membrane compared with wild-type CFTR (wt-CFTR) (20, 29) . Thus little ⌬F508-CFTR is expressed in the plasma membrane (8) . Because ⌬F508-CFTR retains partial function as a cAMP-activated Cl Ϫ channel (11, 28, 39) , identification of drugs that increase the amount and activity of ⌬F508-CFTR in the apical plasma membrane of airway epithelial cells would have important implications for the treatment of CF.
Several experimental maneuvers increase ⌬F508-CFTR expression in the plasma membrane. For example, growing cells in culture treated with reduced temperature (9, 12, 14, 16, 17, 24, 41) , butyrate compounds (19, 24, 41) , and so-called "chemical chaperones" including DMSO and glycerol (41, 43) facilitate the expression of ⌬F508-CFTR in the plasma membrane and allow cAMP to enhance ⌬F508-CFTR-mediated Cl Ϫ permeability (reviewed in Refs. 3 and 47) . However, because many of these studies were conducted in either nonpolarized or heterologous cells, the results should be interpreted cautiously, since it is well known that protein trafficking is cell-type specific and depends on the polarized state of the epithelium (reviewed in Refs. 5 and 6) . For example, the human low-density lipoprotein (LDL) receptor, when expressed in transgenic mice, is located in the apical membrane of renal tubules. By contrast, the LDL receptor is expressed in the basolateral membrane of colonocytes and enterocytes. In addition, in nonpolarized HT-29 intestinal cells, wt-CFTR is localized in an intracellular compartment, whereas in polarized HT-29 cells, wt-CFTR is expressed in the apical plasma membrane (32, 33) . Moreover, cAMP induces the trafficking of wt-CFTR from an intracellular compartment to the plasma membrane in polarized, but not nonpolarized, HT-29 cells (33) . Several laboratories have studied ⌬F508-CFTR trafficking in polarized epithelial cells. Many of these studies have failed to confirm observations made in nonpolarized and/or heterologous cells. For example, in polarized LLC-PK1 cells expressing ⌬F508-CFTR, glycerol, sodium butyrate, or a reduced temperature (27°C) did not stimulate cAMP-stimulated Cl Ϫ secretion (2) . In addition, sodium butyrate had no effect on Cl Ϫ currents across polarized human nasal airway epithelial cells expressing ⌬F508-CFTR (7). Thus studies on polarized epithelial cells have not consistently confirmed results obtained in nonpolarized and/or heterologous cells.
Although LLC-PK1 cells expressing ⌬F508-CFTR form polarized monolayers (2, 10, 20) , additional polarized cell lines expressing ⌬F508-CFTR would be valuable for secondary drug screening studies and to study ⌬F508-CFTR trafficking. Moreover, addition of a green fluorescent protein (GFP) tag on ⌬F508-CFTR would allow investigation of ⌬F508-CFTR trafficking in living, polarized epithelial cells in real time. In preliminary studies, we were unable to identify a robust human airway epithelial cell line that consistently forms polarized monolayers. Thus we have stably expressed ⌬F508-CFTR with a GFP tag in Madin-Darby canine kidney (MDCK) cells, a well-established cell model in which to study protein trafficking in polarized epithelial cells (35) , and have conducted studies to determine whether a reduced temperature, glycerol, butyrate, or DMSO stimulate Cl Ϫ secretion in polarized cells. We attached GFP to the NH 2 terminus of ⌬F508-CFTR to monitor the subcellular localization of ⌬F508-CFTR. GFP, a 27-kDa protein from the jellyfish Aequorea victoria, generates a striking green fluorescence, is resistant to photobleaching, and does not require any exogenous cofactors or substrates to fluoresce (37) . We report that a reduced temperature, glycerol, sodium butyrate, or DMSO has no effect on 8-(4-chlorophenylthio)adenosine 3Ј5Ј-cyclic monophosphate (CPT-cAMP)-stimulated transepithelial Cl Ϫ secretion. However, when the basolateral membrane was permeabilized with nystatin, sodium butyrate increased the CPT-cAMP-stimulated Cl Ϫ current across the apical plasma membrane. Sodium butyrate failed to stimulate transepithelial Cl Ϫ secretion because of inhibitory effects on Cl Ϫ uptake across the basolateral membrane. Reduced temperature, DMSO, and glycerol had no effect on the CPT-cAMPstimulated Cl Ϫ current across the apical plasma membrane. These observations demonstrate that data obtained in heterologous, nonpolarized cell models should be interpreted cautiously. The GFP tag on ⌬F508-CFTR will allow investigation of ⌬F508-CFTR trafficking in living, polarized MDCK epithelial cells in real time.
METHODS
Expression vector. The pGFP-⌬F508-CFTR mammalian expression vector, driven by the cytomegalovirus promoter, was constructed by methods described previously (34, 35) . Proceeding from the NH 2 to the COOH terminus, the resultant chimeric protein consists of enhanced GFP, a flexible linker sequence of 23 amino acids, and ⌬F508-CFTR. The cDNA coding for human ⌬F508-CFTR was a generous gift of Dr. William Guggino (Johns Hopkins University School of Medicine, Baltimore, MD).
Cell culture and stable cell lines. MDCK type I cells (C7 clone, a generous gift of Dr. Hans Oberleithner) stably expressing GFP-⌬F508-CFTR were established by methods described previously (35) . The C7 clonal line expresses very low levels of cAMP-stimulated Cl Ϫ currents attributable to wt-CFTR (18, 31, 35) . Three independent stable cell lines expressing GFP-⌬F508-CFTR were studied to exclude the possibility that results were attributable to clonal variation. MDCK I cells stably expressing GFP-wt-CFTR and parental MDCK I cells (C7) have been characterized and described in detail (34, 35) . Previously, we demonstrated that addition of GFP to the NH 2 terminus of wt-CFTR had no effect on CFTR localization, trafficking, or biophysical properties (35) . Moreover, others have shown that GFP has no effect on the synthesis and degradation of wt-CFTR (25) . In preliminary pulse-chase studies, we observed that GFP does not affect the rate of biosynthesis or degradation of ⌬F508-CFTR. For simplicity, we refer to the chimeric GFP proteins as ⌬F508-CFTR and wt-CFTR.
Immunocytochemistry. Cells grown on glass slides or Transwell filters were fixed in paraformaldehyde and prepared for laser scanning confocal microscopy as described previously (35) . The ER was identified by indirect immunofluoresence with the use of an anti-BiP polyclonal antibody (StressGen Biotechnology, Victoria, BC, Canada) to detect the ER-resident protein BiP, followed by an anti-rabbit Texas Red-labeled secondary antibody (Molecular Probes, Eugene, OR), as described previously (35) .
SDS-PAGE and Western blotting. ⌬F508-CFTR and wt-CFTR were detected on membranes blocked with 5% nonfat dry milk in Tris-buffered saline (TBS)-0.02% Tween 20 using a monoclonal CFTR antibody (M3A7; Chemicon International, Temecula, CA) (26, 27) , followed by anti-mouse horseradish peroxidase (HRP)-conjugated secondary antibody (Amersham, Arlington Heights, IL) as described previously (35) . Blots were developed by enhanced chemiluminescence (ECL) using Hyperfilm ECL (Amersham).
Cell surface biotinylation. Selective apical membrane biotinylation and immunoprecipitation of GFP-CFTR and ⌬F508-CFTR were performed as described in detail previously (34, 35) . All steps were performed at 4°C. Proteins were separated by SDS-PAGE and electrophoretically transferred to polyvinylidene difluoride membranes as described previously (35) . Biotinylated GFP-CFTR fusion proteins were immunoprecipitated with a GFP antibody (1:1,000; Clontech, Palo Alto, CA) and were detected on membranes blocked with 5% nonfat dry milk in TBS-0.02% Tween 20 using a monoclonal CFTR antibody (M3A7) followed by anti-mouse HRPconjugated secondary antibody (1:5,000; Amersham).
Short-circuit current. Short-circuit current (Isc) was measured across MDCK cell monolayers stably expressing ⌬F508-CFTR or wt-CFTR or across MDCK cells not expressing the CFTR transgene, as described previously (35) . In all experiments, amiloride (10 Ϫ5 M) was present in the apical bath solution to inhibit electrogenic Na ϩ absorption. Under these conditions, cAMP-stimulated I sc is referable to CFTRmediated Cl Ϫ secretion from the basolateral to the apical solution (35, 36) . To measure the Cl Ϫ currents across the apical membrane, we permeabilized the basolateral membrane with nystatin (200 g/ml). When the basolateral membrane was permeabilized, Isc measured in the presence of a transepithelial Cl Ϫ ion gradient directed from the basolateral to the apical solution (140 vs. 14 mM: Cl Ϫ was replaced on an equimolar basis with gluconate; Ca 2ϩ was increased from 0.5 to 2 mM in the gluconate-containing solution to maintain Ca 2ϩ activity similar in both solutions) represented the Cl Ϫ current across the apical membrane, as described previously (35) . Cl Ϫ currents are reported as the difference between the peak value of Isc following CPT-cAMP (100 M) minus the steady-state Isc after inhibition of the CPT-cAMP-stimulated CFTR Cl Ϫ current by diphenylamine-2-carboxylic acid (DPC; 3 mM).
Statistical analyses. Differences between means were compared by using the unpaired, two-tailed Student's t-test or by ANOVA followed by a post hoc test (Dunnett's or Tukey's test) as appropriate using Instat v2.01 statistical software (GraphPad, San Diego, CA). Data are expressed as means Ϯ SE. P Ͻ 0.05 is considered significant.
RESULTS

Characterization of ⌬F508-CFTR stable cell lines.
We characterized three independent clonal lines stably expressing ⌬F508-CFTR. First, we conducted Western blots on cell lysates to confirm CFTR protein expression. As demonstrated previously (35) , in cells expressing wt-CFTR, but not in parental nontransfected cells (i.e., C7), we detected two protein bands on Western blots using a monoclonal CFTR antibody (Fig. 1A) . Core glycosylated wt-CFTR had an apparent molecular mass of 210 kDa (the so-called "band B"), and maturely glycosylated wt-CFTR had an apparent molecular mass of 240 kDa (the so-called "band C"). These results confirm our previous study demonstrating that GFPwt-CFTR runs ϳ30 kDa larger than anticipated by SDS-PAGE analysis (35) . By contrast, in cells expressing ⌬F508-CFTR, we only detected core glycosylated band B ⌬F508-CFTR in cells treated with sodium butyrate (Fig. 1B) . We could not detect ⌬F508-CFTR expression in cells not treated with butyrate (Fig. 1B) . Moreover, ⌬F508-CFTR expression was low, even in butyrate-treated cells, relative to the robust expression of wt-CFTR. Lower expression of ⌬F508-CFTR relative to that of wt-CFTR is due in part to the shorter half-life of ⌬F508-CFTR (Ͻ4 h) relative to wt-CFTR (Ͼ24 h) (20, 29) . As expected, ⌬F508-CFTR was expressed in an intracellular compartment, primarily in the ER (Fig. 2) . ⌬F508-CFTR could not be detected in the apical plasma membrane of cells treated with sodium butyrate by selective cell-surface biotinylation. By contrast, the maturely glycosylated band C of wt-CFTR was detected in the apical plasma membrane as described previously (35, 36) .
We also examined the electrophysiological properties of parental MDCK I cells as well as cells stably expressing wt-CFTR and ⌬F508-CFTR. Compared with Fig. 1 . A: Western blot analysis of whole cell lysates from MadinDarby canine kidney (MDCK) parental cells (C7) and MDCK cells expressing wild-type cystic fibrosis transmembrane conductance regulator (wt-CFTR) grown on Transwell filters. Cells were not treated with sodium butyrate. CFTR was not detected in parental C7 cells not expressing the CFTR transgene. Bands B and C of wt-CFTR were detected in MDCK cells stably expressing the wt-CFTR transgene using monoclonal antibody M3A7. When the membranes were stripped and reprobed with an anti-green fluorescent protein (GFP) monoclonal antibody, as described previously (35), similar results were obtained (data not shown). B: band B of ⌬F508-CFTR, but not band C, is evident only in cells treated with sodium butyrate (⌬F508 ϩ NaB; 5 mM) overnight, not in untreated cells (⌬F508). The predicted molecular masses of GFP (27 kDa plus a 3-kDa flexible linker sequence) fused to core glycosylated (150 kDa) and mature glycosylated (180 kDa) forms of CFTR are predicted to run at 180 and 210 kDa, respectively (35) . The molecular mass of band B of CFTR was ϳ210 kDa, and the mature glycosylated band C of CFTR was ϳ240 kDa. Thus, as shown previously (35), GFP-CFTR fusion proteins run ϳ30 kDa larger than anticipated by SDS-PAGE. Glycoproteins, including CFTR, frequently migrate slower than predicted because SDS does not bind sugar moieties, and, as a result, migration toward the positive electrode is hindered (31, 35) . In A and B, 50 g/protein were loaded per lane. the parental nontransfected cells, stable expression of wt-CFTR increased basal I sc (i.e., unstimulated I sc ) and CPT-cAMP stimulated I sc (Table 1 ). These data confirm previous observations that wt-CFTR functions as a cAMP-stimulated Cl Ϫ channel and mediates Cl Ϫ secretion across polarized MDCK I cells (35) . Stable transfection of ⌬F508-CFTR had no effect on basal or CPTcAMP-stimulated I sc compared with parental nontransfected cells (Table 1) . These functional data are consistent with the view that ⌬F508-CFTR does not traffic to the apical plasma membrane. Together, Western blot analysis, laser scanning microscopy, and electrophysiological studies demonstrate that in polarized MDCK cells, ⌬F508-CFTR is expressed primarily in the ER.
Low temperature, butyrate, glycerol, and DMSO do not increase CPT-cAMP-stimulated transepithelial Cl Ϫ secretion. We examined the effect of reduced temperature, sodium butyrate, glycerol, and DMSO on the ability of CPT-cAMP to stimulate Cl Ϫ secretion in polarized MDCK cells stably expressing ⌬F508-CFTR. The effect of sodium butyrate on the CPT-cAMP-stimulated I sc is summarized in Fig. 3 . Cells were exposed to sodium butyrate (1 or 5 mM) for 1, 3, or 5 days. Similar experimental maneuvers stimulate Cl Ϫ permeability in several other cell types expressing ⌬F508-CFTR (1, 7, 19, 41) . Stock solutions of sodium butyrate were made immediately before addition to the cell culture medium, and the butyrate containing cell culture medium was changed daily. Although sodium butyrate dramatically increased ⌬F508-CFTR protein expression (see Fig. 1B ), butyrate had no effect on CPTcAMP-stimulated I sc (Fig. 3) .
The effect of reducing the temperature to 27°C for 1, 2, or 3 days on the CPT-cAMP-stimulated I sc also is summarized in Fig. 3 . Similar experimental maneuvers stimulate membrane Cl Ϫ permeability in numerous cell types expressing ⌬F508-CFTR (12, 16, 17, 19, 41) . However, reducing the temperature to 27°C had no effect on the CPT-cAMP-stimulated I sc across polarized MDCK cells expressing ⌬F508-CFTR (Fig. 3) . In a recent study, plasma membrane expression of ⌬F508-CFTR was markedly enhanced by combination treatment with sodium butyrate and low temperature (19) . Sodium butyrate (5 mM) and 25°C for 48-60 h had a maximum stimulatory effect. However, as demonstrated in Fig. 3 , a combination of sodium butyrate (5 mM) and 27°C for 1 or 2 days had no effect on the CPT-cAMP-stimulated I sc across polarized MDCK cells expressing ⌬F508-CFTR.
We also examined the effect of glycerol in the cell culture medium on the ability of CPT-cAMP to stimulate I sc . Glycerol (10, 7.5, 5, or 2.5%) was added to the cell culture medium for 2 days, a protocol that stimulates Cl Ϫ permeability in a variety of cells expressing ⌬F508-CFTR (4, 43). High concentrations of glycerol (10%) disrupted the integrity of MDCK monolayers such that we could not measure I sc or transepithelial resistance (R t ) (n ϭ 9 monolayers). Lower concentrations of glycerol (7.5, 5, or 2.5%) had no effect on the CPT-cAMP-stimulated I sc (Fig. 3) . DMSO (2% for 3 Values are means Ϯ SE; n ϭ no. of monolayers. Transepithelial voltage (Vt) was measured under open circuit conditions. Transepithelial resistance (Rt) and short-circuit current (Isc) were measured under short-circuit conditions as described previously (35) . Rt was measured before addition of 8-(4-chlorophenylthio)-cAMP (CPT-cAMP). In each of the 3 Madin-Darby canine kidney (MDCK) clones expressing ⌬F508-CFTR examined, Rt was lower than in the parental cells and in all 3 MDCK clones expressing wild-type cystic fibrosis transmembrane conductance regulator (wt-CFTR). Although the reason for the reduction in Rt is unknown, MDCK cells expressing ⌬F508-CFTR were polarized inasmuch as Na ϩ -K ϩ -ATPase was expressed exclusively in the basolateral plasma membrane. * P Ͻ 0.001 vs. parental cells. Fig. 3 . Transepithelial Cl Ϫ secretion, reported as the 8-(4-chlorophenylthio)-cAMP (CPT-cAMP; 100 M) stimulated and diphenylamine-2-carboxylic acid (DPC; 3 mM)-inhibited short-circuit currents (Isc) across MDCK I cells stably expressing ⌬F508-CFTR. Control, n ϭ 29 monolayers; NaB (sodium butyrate), n ϭ 10 monolayers on day 1, 13 monolayers on day 3, and 13 monolayers on day 5; 27°C, n ϭ 14 monolayers on day 1, 14 monolayers on day 2, and 10 monolayers on day 3; 27°C ϩ NaB, n ϭ 8 monolayers on day 1 and 7 monolayers on day 2; glycerol, n ϭ 3 monolayers with 7.5, 5.0, and 2.5%; and DMSO, n ϭ 15 monolayers. Details on experimental treatments are described in RESULTS. Isc are reported as the difference between the peak value of Isc following CPT-cAMP minus the steady-state Isc after DPC (3 mM) inhibition of CPT-cAMP-stimulated Isc. days) also enhances cAMP-stimulated I sc across polarized LLC-PK1 cells expressing ⌬F508-CFTR (2). However, DMSO treatment for 3 days had no effect on the CPT-cAMP-stimulated I sc (Fig. 3) . Together, these data suggest that a reduced temperature, butyrate, or "chemical chaperones" including glycerol and DMSO do not facilitate the trafficking of functional ⌬F508-CFTR channels to the apical membrane.
⌬F508-CFTR channel activity and Cl Ϫ electrochemical driving force. The inability to detect an increase in CPT-cAMP-stimulated Cl Ϫ secretion in cells treated with sodium butyrate in the present study may be due to a low open probability of ⌬F508-CFTR channels in the plasma membrane (21, 22) . To test this possibility, we added genistein, a flavinoid that increases the open probability of ⌬F508-CFTR channels (1, 14) , to the apical bathing solution after addition of CPT-cAMP. Genistein (50 M) had no effect on I sc across control or sodium butyrate-treated monolayers (5 mM for 2 days). The change in I sc with genistein was 0.1 Ϯ 1.1 A/cm 2 in control monolayers and 2.1 Ϯ 0.8 A/cm 2 in monolayers treated with sodium butyrate [n ϭ 6 monolayers/group, P ϭ NS (not significant)]. Thus the lack of effect of sodium butyrate on CPT-cAMP-stimulated Cl Ϫ secretion did not appear to be due to a reduced activity of ⌬F508-CFTR channels in the apical plasma membrane.
Additional studies were conducted to determine whether the inability of butyrate compounds to stimulate CPT-cAMP-stimulated I sc was due to a lack of a sufficient electrochemical gradient to drive Cl Ϫ across the apical plasma membrane. To increase the driving force for Cl Ϫ movement across the apical membrane, we treated monolayers with 1-EBIO (300 M), a drug that activates K ϩ channels in the basolateral membrane and hyperpolarizes the basolateral and apical membrane potentials (14, 15) . This, in turn, enhances the electrochemical driving force promoting Cl Ϫ secretion across the apical plasma membrane (14, 15) . 1-EBIO also stimulates CFTR (14, 15) . 1-EBIO (300 M) added to the basolateral bath solution after CPT-cAMP had no significant effect on I sc , which changed by 0.4 Ϯ 0.2 A/cm 2 in untreated cells and 2.8 Ϯ 2.3 A/cm 2 in sodium butyrate-treated cells (5 mM for 2 days: n ϭ 6 monolayers/group, P ϭ NS). Thus it is unlikely that the lack of effect of sodium butyrate on Cl Ϫ secretion was due to a lack of a sufficient electrochemical gradient to drive Cl Ϫ secretion across the apical membrane. However, these data should be interpreted cautiously because we did not test whether 1-EBIO activates K ϩ channels in the basolateral membrane and increases the electrochemical gradient for Cl Ϫ across the apical plasma membrane. Thus additional studies were conducted to determine whether sodium butyrate and the other experimental maneuvers described above increased the amount of functional ⌬F508-CFTR in the apical plasma membrane.
Apical membrane ⌬F508-CFTR currents. To examine the effect of sodium butyrate, reduced temperature, glycerol, and DMSO on Cl Ϫ currents across the apical membrane of cells expressing ⌬F508-CFTR, we permeabilized the basolateral membrane with nystatin and measured CPT-cAMP-stimulated I sc across the apical membrane as described in METHODS. The data are summarized in Fig. 4 , and representative experiments are illustrated in Fig. 5 . Only sodium butyrate significantly increased the Cl Ϫ currents across the apical membrane. In untreated monolayers expressing ⌬F508-CFTR, the CPT-cAMP-stimulated I sc was 11.8 Ϯ 2.7 A/cm 2 . Sodium butyrate increased the CPT-cAMP-stimulated I sc in monolayers expressing ⌬F508-CFTR to 33.6 Ϯ 5.4 A/cm 2 (P Ͻ 0.05 compared with control). However, a reduced temperature, DMSO, or glycerol did not increase the Cl Ϫ current across the apical membrane (Fig. 4) . Moreover, a combination of sodium butyrate and reduced temperature did not increase the Cl Ϫ current compared with sodium butyrate treatment alone (Fig. 4) . In addition, a combination of sodium butyrate and glycerol or sodium butyrate and DMSO failed to increased the Cl Ϫ current compared with sodium butyrate treatment alone (Fig.  4) . These data, in combination with studies described below, demonstrate that sodium butyrate increased the amount of functional ⌬F508-CFTR in the apical plasma membrane of polarized MDCK cells.
Sodium butyrate had no effect on endogenous wt-CFTR Cl Ϫ currents in parental MDCK I cells. Because the parental MDCK I (C7) cell line expresses low levels of endogenous wt-CFTR (31), it is possible that sodium butyrate stimulated Cl Ϫ currents across the apical membrane of cells stably expressing ⌬F508-CFTR by increasing endogenous wt-CFTR expression. To examine this possibility, we treated MDCK I parental cells with sodium butyrate (5 mM for 2 Fig. 4 . Cl Ϫ currents across the apical plasma membrane of cells stably expressing ⌬F508-CFTR. Control (no treatment), n ϭ 14 monolayers; NaB, n ϭ 16 monolayers; 27°C, n ϭ 11 monolayers; glycerol, n ϭ 9 monolayers; DMSO, n ϭ 7 monolayers; NaB ϩ 27°C, n ϭ 7 monolayers; NaB ϩ glycerol, n ϭ 9 monolayers; and NaB ϩ DMSO, n ϭ 7 monolayers. Details on experimental treatments are presented in RESULTS. Isc are reported as the difference between the peak value of Isc following CPT-cAMP minus the steady-state Isc after DPC (3 mM) inhibition of CPT-cAMP-stimulated Isc. A transepithelial Cl Ϫ ion gradient was directed from the basolateral to the apical solution (140 vs. 14 mM). *P Ͻ 0.05 vs. control. days). CPT-cAMP-stimulated transepithelial Cl Ϫ secretion was 2.5 Ϯ 0.5 A/cm 2 in control untreated monolayers and 0.5 Ϯ 0.3 A/cm 2 in sodium butyrate-treated monolayers (n ϭ 6, P Ͻ 0.05). Next, the Cl Ϫ current across the apical plasma membrane was measured in the presence of nystatin to permeabilize the basolateral membrane. Sodium butyrate had no effect on the CPT-cAMP-stimulated Cl Ϫ current across the apical membrane, which was 9.0 Ϯ 1.5 A/cm 2 in untreated monolayers and 11.6 Ϯ 0.9 A/cm 2 in sodium butyrate-treated monolayers (5 mM for 2 days: n ϭ 7 monolayers/group, P ϭ NS). These data demonstrate that sodium butyrate does not increase the functional expression of endogenous wt-CFTR in the apical membrane of parental MDCK cells. Thus the effects of sodium butyrate in MDCK cells expressing ⌬F508-CFTR, described above, are due to increased functional expression of ⌬F508-CFTR in the apical plasma membrane and not to the enhanced expression of endogenous wt-CFTR.
DISCUSSION
A new polarized epithelial cell line in which to study ⌬F508-CFTR trafficking. We have established and characterized a new polarized cell line stably expressing GFP-tagged ⌬F508-CFTR. MDCK I cells form polarized monolayers, are robust and easy to maintain in culture, express low levels of endogenous CFTR, have R t values ϳ400 ⍀ ⅐ cm 2 , and are a well-established model in which to study trafficking of ion channels. In addition, Ussing chamber studies can be performed to monitor transepithelial Cl Ϫ secretion as well as Cl Ϫ secretion across the apical plasma membrane. As expected, ⌬F508-CFTR was expressed primarily in the ER. However, sodium butyrate increased the functional expression of ⌬F508-CFTR in the apical plasma membrane. The GFP tag on ⌬F508-CFTR will allow, in future studies, investigation of ⌬F508-CFTR trafficking in living, polarized MDCK epithelial cells in real time.
In extensive preliminary studies, we examined the ability of several human airway epithelial cell lines expressing endogenous ⌬F508-CFTR to polarize and establish a R t in culture, including, for example, CFT1, CFBE14oϪ and ¥CFTE-29oϪ (23, 24, 38) . Although others have reported that these cells lines develop a R t , we found these cell lines, relative to MDCK cells, difficult to maintain in culture and were unable to obtain R t values above 100 ⍀ ⅐ cm 2 on a consistent basis (i.e., Ͻ10% of monolayers tested had R t values Ͼ100 ⍀ ⅐ cm 2 ). Thus, although polarized monolayers of human airway epithelial cells would be the most preferable model in which to study ⌬F508-CFTR trafficking, we could not identify a robust human cell line that polarized in a reproducible manner.
Butyrate increases functional ⌬F508-CFTR expression in the apical plasma membrane. Sodium butyrate increased the amount of functional ⌬F508-CFTR in the apical plasma membrane as determined by measuring the CPT-cAMP-stimulated, DPC-sensitive Cl Ϫ current across the membrane. Thus, as in many cell types, sodium butyrate increases the plasma membrane expression of ⌬F508-CFTR. However, we did not detect ⌬F508-CFTR in the apical membrane by cell surface biotinylation, and we did not detect maturely glycosylated (band C) ⌬F508-CFTR by Western blot analysis. Similar results were observed in LLC-PK1 cells stably expressing ⌬F508-CFTR (20) . Thus it is not surprising that ⌬F508-CFTR in the apical membrane was below the detection limit of Western blot analysis and selective cell surface biotinylation. Plasma membrane expression of ⌬F508-CFTR in vivo is also very low compared with the expression of wt-CFTR.
The results in this study support a growing body of evidence to support the view that ⌬F508-CFTR trafficking is cell-type dependent. In addition, we speculate that ⌬F508-CFTR trafficking, like wt-CFTR trafficking (33) , may depend on the state of cell polarization. Of Representative experiments illustrating the effect of sodium butyrate on the Cl Ϫ current across the apical membrane in cells expressing ⌬F508-CFTR. Records are from monolayers at passage 12 treated with vehicle (distilled water) or sodium butyrate (5 mM for 24 h). Nystatin (200 g/ml) was added to the basolateral bath solution of both monolayers as indicated by arrow, and ϳ20 min later CPT-cAMP (100 M) was added to the apical and basolateral solutions of control (solid line) and sodium butyrate-treated monolayers (shaded line). In these representative experiments, CPT-cAMP increased Isc by 39.1 A/cm 2 in the monolayer treated with sodium butyrate and by 10.2 A/cm 2 in the control monolayer. Genistein (50 M), which activates ⌬F508-CFTR, added to the apical bath solution increased Isc by 13.4 A/cm 2 in the sodium butyrate-treated monolayer and had no effect in the control monolayer. Finally, DPC (3 mM) added to the apical and basolateral solutions completely inhibited the CPTcAMP-stimulated Isc in both monolayers. These results are consistent with the view that sodium butyrate increases the amount of functional ⌬F508-CFTR in the apical plasma membrane. By comparison, in a previous study we reported that in MDCK cells stably expressing wt-CFTR, CPT-cAMP increased Isc by 9.2 A/ cm 2 in untreated monolayers and by 274.6 A/cm 2 in monolayers treated with sodium butyrate (36) . Moreover, as stated in RESULTS, sodium butyrate had no effect on the CPT-cAMP-stimulated Cl Ϫ current across the apical membrane in parental C7 cells. Thus the effect of butyrate to increase Cl Ϫ current across the apical plasma membrane can be attributed to GFP-⌬F508-CFTR. the experimental maneuvers tested, only sodium butyrate increased the functional expression of ⌬F508-CFTR in the apical plasma membrane of polarized MDCK cells. A reduced temperature, glycerol, or DMSO did not increase the amount of ⌬F508-CFTR in the apical plasma membrane, even when ⌬F508-CFTR expression was increased by pretreatment with sodium butyrate. By contrast, in several heterologous cells and/or nonpolarized epithelial cells, these experimental maneuvers increased the amount of ⌬F508-CFTR in the plasma membrane (see Introduction). It is unlikely that the lack of effect of these experimental maneuvers on polarized MDCK cells is due to differences in protocol between this and previous studies, since our protocols, including concentrations and times of exposure, were similar to those reported previously. Moreover, other investigators have noted a similar lack of effect of these experimental maneuvers on Cl Ϫ transport in polarized epithelial cells. For example, glycerol, sodium butyrate, or a reduced temperature had no effect on cAMP-stimulated Cl Ϫ secretion in polarized LLC-PK1 cells expressing ⌬F508-CFTR (2). Finally, sodium butyrate had no effect on Cl Ϫ currents across polarized human nasal airway epithelial cells expressing ⌬F508-CFTR (7). However, several experimental maneuvers including DMSO, 4-phenylbutyrate, and reduced temperature have been shown to increase ⌬F508-CFTR in the plasma membrane of polarized epithelial cells (2, 14, 42) . Thus, together, the data support the view that the effect of a reduced temperature, glycerol, or DMSO on ⌬F508-CFTR trafficking may be cell-type dependent (i.e., kidney, airway, fibroblast) and may also depend on the state of polarization. 1 Additional studies are required to test these hypotheses directly.
Untoward effects of sodium butyrate on transepithelial Cl Ϫ secretion. Why did sodium butyrate have no effect on CPT-cAMP-stimulated transepithelial Cl Ϫ secretion but increase CPT-cAMP-stimulated Cl Ϫ secretion across the apical plasma membrane in MDCK cells expressing ⌬F508-CFTR? Previously, we reported that sodium butyrate increased the expression of wt-CFTR in the apical membrane of MDCK I cells 25-fold and stimulated Cl Ϫ currents across the apical membrane 30-fold (36) . However, transepithelial CPT-cAMPstimulated Cl Ϫ secretion was reduced because butyrate reduced the activity of the Na ϩ -K ϩ -ATPase. In epithelial cells, the Na ϩ -K ϩ -ATPase maintains a low intracellular concentration of Na ϩ , which is important for providing the driving force for Cl Ϫ entry into the cell across the basolateral membrane via the Na
Ϫ then exits the cell across the apical membrane through CFTR Cl Ϫ channels. By reducing the activity of the Na ϩ -K ϩ -ATPase, we speculated that sodium butyrate increases intracellular Na ϩ concentration and thereby reduces Cl Ϫ entry into the cell across the basolateral membrane via the Na ϩ -K ϩ -2Cl Ϫ cotransporter. The decrease in Cl Ϫ entry would reduce intracellular Cl Ϫ concentration and thereby inhibit Cl Ϫ secretion across the apical membrane. The present study also supports the view that despite an increase in the amount of ⌬F508-CFTR in the apical membrane, sodium butyrate does not increase transepithelial CPT-cAMP-stimulated Cl Ϫ secretion, most likely because sodium butyrate inhibits the Na ϩ -K ϩ -ATPase and indirectly reduces Cl Ϫ uptake across the basolateral membrane. It is possible, but not proven, that the inability of sodium butyrate to stimulate Cl Ϫ secretion across polarized epithelial MDCK cells expressing ⌬F508-CFTR could be due to a similar effect of butyrate on the Na ϩ -K ϩ -ATPase. Additional experiments, beyond the scope of this report, are required to elucidate the cellular mechanism(s) whereby butyrate inhibits Na ϩ -K ϩ -ATPase activity in MDCK cells expressing ⌬F508-CFTR.
In conclusion, our data, as well as other data in the literature, suggest that CF drug studies conducted on heterologous and/or nonpolarized cells should be interpreted cautiously. This is not to say that nonpolarized and/or heterologous cell models are not valuable tools for drug discovery. Many nonpolarized and/or heterologous models are ideal for high-throughput screening and rapid identification of candidate drugs to either move ⌬F508-CFTR to the plasma membrane or increase ⌬F508-CFTR channel activity. However, our results, together with other data in the literature indicating that CFTR trafficking is cell-type dependent and may depend on the state of polarization, suggest that once a drug is identified, secondary assays should be performed, ideally in polarized human airway epithelial cells lines expressing ⌬F508-CFTR. At the present time, however, we are not aware of any robust models currently available. Until such cells lines are available, MDCK (present study) and LLC-PK1 cells (2, 10, 20) , and perhaps FRT cells (44, 45) , expressing ⌬F508-CFTR may prove useful in secondary drug screens.
